ALLMedicine™ Kaposi Sarcoma Center

Mar 31st, 2023 - PRIMARY OBJECTIVE: I. To assess the proportion of participants with Kaposi sarcoma (KS) (with or without human immunodeficiency virus [HIV], regardless of previous treatment status) treated with pomalidomide who respond to treatment with a durable...

Mar 30th, 2023 - PRIMARY OBJECTIVE: I. Determine the overall response rate of ixazomib in participants with Kaposi sarcoma. SECONDARY OBJECTIVES: I. Determine safety and tolerability of ixazomib. II. Assess changes in Kaposi-sarcoma associated herpesvirus (KSHV) v...

Mar 29th, 2023 - Background: Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor that most frequently involves skin, but can also involve lymph nodes, lungs and gastrointestinal tract. It is most common in people with HIV or other forms of immune compro...

Mar 29th, 2023 - Practice Essentials In 1981, Kaposi sarcoma seen in AIDS (KS-AIDS) in America was identified in 3 reports of Kaposi sarcoma as an original defining element of what later became known as AIDS (plus an important editorial and a Centers for Disease C...

Mar 29th, 2023 - Practice Essentials In 1981, Kaposi sarcoma seen in AIDS (KS-AIDS) in America was identified in 3 reports of Kaposi sarcoma as an original defining element of what later became known as AIDS (plus an important editorial and a Centers for Disease C...

Mar 31st, 2023 - PRIMARY OBJECTIVE: I. To assess the proportion of participants with Kaposi sarcoma (KS) (with or without human immunodeficiency virus [HIV], regardless of previous treatment status) treated with pomalidomide who respond to treatment with a durable...

Mar 30th, 2023 - PRIMARY OBJECTIVE: I. Determine the overall response rate of ixazomib in participants with Kaposi sarcoma. SECONDARY OBJECTIVES: I. Determine safety and tolerability of ixazomib. II. Assess changes in Kaposi-sarcoma associated herpesvirus (KSHV) v...

Mar 29th, 2023 - Background: Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor that most frequently involves skin, but can also involve lymph nodes, lungs and gastrointestinal tract. It is most common in people with HIV or other forms of immune compro...

Mar 29th, 2023 - PRIMARY OBJECTIVES: I. To assess the safety and tolerability of MK-3475 (pembrolizumab) in HIV-infected patients on effective antiretroviral therapy and with relapsed/refractory or disseminated acquired immune deficiency syndrome (AIDS)-defining o...

Mar 27th, 2023 - BACKGROUND: KSHV inflammatory cytokine syndrome (KICS) is a newly recognized syndrome caused by Kaposi sarcoma-associated herpesvirus (KSHV). It is characterized by severe inflammatory symptoms including fevers, wasting, cytopenias, hypoalbuminemi...

Dec 29th, 2022 - Steven R. Feldman, MD, PhD I'm spoiled.

Oct 6th, 2022 - Lung cancer rates declined for people living with HIV but remained higher than the general population and, in older individuals, even higher than other cancers normally considered to be associated with HIV/AIDS, a population-based registry linkage...

Jun 2nd, 2022 - To the Editor: Postirradiation pseudosclerodermatous panniculitis (PIPP) is a rarely reported complication of megavoltage external beam radiotherapy that was first identified in 1993 by Winkelmann et al. 1 The condition presents as an erythematous.

May 16th, 2022 - Penile cancer is rare with a worldwide incidence of 0. 8 cases per 100,000 men.

May 4th, 2022 - Adolescent and young adult (AYA) cancer survivors have a significantly increased risk for developing a new cancer and dying from that cancer, according to a population-based study. These younger cancer survivors had a 25% higher risk for cancer in...